Breaking News Instant updates and real-time market news.

AZO

AutoZone

$879.44

11.34 (1.31%)

, ORLY

O'Reilly Automotive

$365.46

11.61 (3.28%)

06:55
02/08/19
02/08
06:55
02/08/19
06:55

AutoZone downgraded to Perform from Outperform at Oppenheimer

Oppenheimer analyst Brian Nagel downgraded AutoZone (AZO) to Perform from Outperform, telling investors that from the consumer perspective, investor angst towards a potential marked economic downturn seems overblown. Valuations, while not depressed, have moderated, and seem to discount for a sustained deceleration in spending, Nagel says, adding that he believes AutoZone and O'Reilly Auto (ORLY) have benefited as investors sought counter-cyclical safety. He does not foresee any type of fundamental deterioration at either AutoZone or O'Reilly, he notes. Nagel raised his price target to $900 from $860.

AZO

AutoZone

$879.44

11.34 (1.31%)

ORLY

O'Reilly Automotive

$365.46

11.61 (3.28%)

  • 06

    Mar

AZO AutoZone
$879.44

11.34 (1.31%)

12/03/18
SBSH
12/03/18
DOWNGRADE
Target $238
SBSH
Neutral
Costco downgraded to Neutral from Buy at Citi
Citi analyst Kate McShane downgraded Costco Wholesale (COST) and lowered her price target for the shares to $238 from $257. The analyst sees "more headwinds than tailwinds likely in 2019" for Costco. Her top Hardlines & Broadlines idea for 2019 is AutoZone (AZO) and her favored smaller cap ideas are BJ's Wholesale (BJ) and RH (RH).
12/05/18
SPHN
12/05/18
NO CHANGE
Target $975
SPHN
Overweight
AutoZone price target raised to $975 from $875 at Stephens
Stephens analyst Daniel Imbro raised his price target for AutoZone to $975 and reiterates an Overweight rating on the shares following the company's Q1 results. Improving demand trends and easier upcoming same-store-sales compares suggest there is room for multiple expansion, Imbro tells investors in a research note.
12/06/18
ARGS
12/06/18
NO CHANGE
Target $940
ARGS
Buy
AutoZone price target raised to $940 from $818 at Argus
Argus analyst Deborah Ciervo raised her price target on AutoZone to $940 and kept her Buy rating after its Q1 earnings and revenue beat, with the upside "driven by the 11% growth in its Commercial Sales segment." The analyst expects the company to continue to benefit from "solid industry fundamentals, which include an aging vehicle fleet, low gasoline prices, and increasing miles driven per car", also raising her FY19 EPS view to $58.25 from $56.50 and FY20 to $62 from $60.
02/08/19
OPCO
02/08/19
DOWNGRADE
OPCO
Perform
AutoZone downgraded to Perform from Outperform at Oppenheimer
ORLY O'Reilly Automotive
$365.46

11.61 (3.28%)

01/02/19
SPHN
01/02/19
NO CHANGE
SPHN
CBS, Global Payments, Union Pacific among Stephens' best ideas for 2019
Stephens released its Best Ideas list for 2019, noting that over the last 13 years its Best Ideas list has outperformed the Russell 2000 by an average of 300 bps. Of note, six of the firm's 30 analysts listed "cash" as their best idea for this year. Among the rest, the picks included: Landstar System (LSTR), Enova (ENVA), RealPage (RP), FMC Corporation (FMC), Avanos (AVNS), Knight-Swift (KNX), CBS (CBS), Vulcan Materials (VMC), Encompass Health (EHC), Watsco (WSO), Global Payments (GPN), O'Reilly Automotive (ORLY), NeoGenomics (NEO), Continental Resources (CLR), Union Pacific (UNP), Ametek (AME), Wintrust Financial (WTFC), Helmerich & Payne (HP), Penske Automotive (PAG), Signature Bank (SBNY), Noble Energy (NBL), Origin Bancorp (OBNK), GrubHub (GRUB) and CenterState Bank (CSFL).
01/07/19
LEHM
01/07/19
UPGRADE
Target $205
LEHM
Overweight
Advance Auto Parts upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Matthew McClintock upgraded Advance Auto Parts to Overweight and raised his price target for the shares to $205 from $170. The analyst now feels confident that a "stable base for operations has been established." This provides management with the ability to shift the focus towards "ample opportunities for value creation," McClintock tells investors in a research note. He points out that Q3 was Advance Auto's best comp since 2010 and the first time the company out-comped industry leader O'Reilly Automotive (ORLY) since Q1 of 2010.
02/07/19
UBSW
02/07/19
NO CHANGE
Target $395
UBSW
Buy
O'Reilly Automotive Q4 results had 'more good than bad,' says UBS
UBS analyst Michael Lasser said O'Reilly Automotive's Q4 results had "more good than bad" and show that they are set up well for 2019. The analyst said the comps fell short of his estimates but he believes it was due to unfavorable weather in late December. Despite the shortfall, he thinks margins saw gains. Lasser reiterated his Buy rating and $395 price target on O'Reilly Automotive shares.
02/08/19
OPCO
02/08/19
DOWNGRADE
OPCO
Perform
O'Reilly Automotive downgraded to Perform from Outperform at Oppenheimer

TODAY'S FREE FLY STORIES

CR

Crane

$86.50

0.99 (1.16%)

, CIR

Circor

$39.83

1.17 (3.03%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Recommendations
Crane, Circor analyst commentary  »

Crane Q2 highlighted by…

CR

Crane

$86.50

0.99 (1.16%)

CIR

Circor

$39.83

1.17 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

RLGY

Realogy

$5.17

-0.08 (-1.52%)

, AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Hot Stocks
Realogy launches TurnKey in collaboration with Amazon »

Realogy (RLGY) announced…

RLGY

Realogy

$5.17

-0.08 (-1.52%)

AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

AN

AutoNation

$42.01

-0.045 (-0.11%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Recommendations
AutoNation analyst commentary  »

Stephens 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

MYOV

Myovant Sciences

$8.15

-0.25 (-2.98%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Hot Stocks
Myovant Sciences says primary efficacy endpoint met in LIBERTY 2 study »

Myovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Earnings
Kimberly-Clark sees FY19 net sales flat to down 1% y/y, consensus $18.41B »

Prior assumption was down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FB

Facebook

$202.32

3.94 (1.99%)

07:35
07/23/19
07/23
07:35
07/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ARAY

Accuray

$3.91

-0.07 (-1.76%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
CNNC Accuray Medical Technology receives safety license in China »

Accuray provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
Cytokinetics granted European orphan designation for reldesemtiv »

Cytokinetics Incorporated…

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Hot Stocks
Kimberly-Clark CEO says 'we made excellent progress in the second quarter' »

CEO Mike Hsu said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LECO

Lincoln Electric

$85.18

0.39 (0.46%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lincoln Electric reports Q2 adjusted EPS $1.28, consensus $1.27 »

Reports Q2 revenue $777M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lockheed Martin raises FY19 EPS view to $20.85-$21.15 from $20.05-$20.35 »

Consensus is $20.57.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

INGR

Ingredion

$80.40

-0.705 (-0.87%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 22

    Aug

  • 19

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Kimberly-Clark raises FY19 adj. EPS view to $6.65-$6.80 from $6.50-$6.70 »

FY19 consensus $6.72. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SEDG

SolarEdge

$63.08

-0.2 (-0.32%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Recommendations
SolarEdge analyst commentary at Canaccord »

SolarEdge price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Earnings
Lockheed Martin reports Q2 EPS $5.00, consensus $4.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Earnings
Kimberly-Clark reports Q2 adjusted EPS $1.67, consensus $1.61 »

Reports Q2 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

T

AT&T

$32.14

-0.63 (-1.92%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

WDDMF

WeedMD

$0.00

(0.00%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Hot Stocks
WeedMD launches cannabis extraction affiliate CX Industries »

WeedMD announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated at BTIG »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary at Credit Suisse »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary at H.C. Wainwright »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.